Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel Pharmacokinetics

J. S. Lagas, M. L. Vlaming, O. van Tellingen, E. Wagenaar, R. S. Jansen, H. Rosing, J. H. Beijnen, A. H. Schinkel
  • Clinical Cancer Research, October 2006, American Association for Cancer Research (AACR)
  • DOI: 10.1158/1078-0432.ccr-06-1352
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
Read Publication

http://dx.doi.org/10.1158/1078-0432.ccr-06-1352

The following have contributed to this page: Robert Jansen